Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
6,713,803
-
Total 13F shares
-
281,633
-
Share change
-
-185,162
-
Total reported value
-
$802,423
-
Price per share
-
$2.85
-
Number of holders
-
19
-
Value change
-
-$1,021,559
-
Number of buys
-
12
-
Number of sells
-
5
Institutional Holders of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) as of Q1 2025
As of 31 Mar 2025,
Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
281,633 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, Cutter & CO Brokerage, Inc., VANGUARD GROUP INC, ENVESTNET ASSET MANAGEMENT INC, COMMONWEALTH EQUITY SERVICES, LLC, ROYAL BANK OF CANADA, NORTHERN TRUST CORP, STATE STREET CORP, EWA, LLC, and Credit Agricole S A.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.